A lamentable, widespread and inefficient habit in analysing clinical trials
is to take continuous measurements and dichotomise them prior to analysis.
(In particular patients are frequently analysed as responders or not.) I
have my own opinion as to the losses involved in doing this but would like
to acknowledge priority in what must have been a question that has long
been studied. I should be grateful for any references to the published
literature.
Regards
Stephen Senn
==============================================
Stephen Senn
Professor of Statistics
Department of Statistics
15 University Gardens
<http://www.gla.ac.uk>University of Glasgow
G12 8QQ
Tel: +44 (0)141 330 5141
Fax: +44(0)141 330 4814
email [log in to unmask]
Private webpage: http://www.senns.demon.co.uk/home.html
===============================================
|